Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Frontotemporal dementia (FTD) is the second most common cause of dementia in people under the age of 65 years. A large proportion of FTD patients (35-50%) have a family history of dementia, consistent with a strong genetic component to the disease. In 1998, mutations in the gene encoding the microtubule-associated protein tau (MAPT) were shown to cause familial FTD with parkinsonism linked to chromosome 17q21 (FTDP-17). The neuropathology of patients with defined MAPT mutations is characterized by cytoplasmic neurofibrillary inclusions composed of hyperphosphorylated tau. However, in multiple FTD families with significant evidence for linkage to the same region on chromosome 17q21 (D17S1787-D17S806), mutations in MAPT have not been found and the patients consistently lack tau-immunoreactive inclusion pathology. In contrast, these patients have ubiquitin (ub)-immunoreactive neuronal cytoplasmic inclusions and characteristic lentiform ub-immunoreactive neuronal intranuclear inclusions. Here we demonstrate that in these families, FTD is caused by mutations in progranulin (PGRN) that are likely to create null alleles. PGRN is located 1.7 Mb centromeric of MAPT on chromosome 17q21.31 and encodes a 68.5-kDa secreted growth factor involved in the regulation of multiple processes including development, wound repair and inflammation. PGRN has also been strongly linked to tumorigenesis. Moreover, PGRN expression is increased in activated microglia in many neurodegenerative diseases including Creutzfeldt-Jakob disease, motor neuron disease and Alzheimer's disease. Our results identify mutations in PGRN as a cause of neurodegenerative disease and indicate the importance of PGRN function for neuronal survival.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“has been implicated in frontotemporal dementia in humans and mice”
From Cross-Species Single-Cell Analysis Reveals Divergence of the Primate Microglia Program (2019) · cites this paper as Baker et al., 2006
In the citing paper
“Importantly, while abnormal proteostasis is a hallmark of aging and misfolded proteins are a key feature in both LSDs and neurodegeneration, other macromolecules are processed by the lysosome, evidenced by the finding that both lipid and carbohydrate metabolism are disrupted in these diseases throughout the lifespan.12,13”
From The lysosome and proteostatic stress at the intersection of pediatric neurological disorders and adult neurodegenerative diseases (2025) · cites this paper as [12]
In the citing paper
“Haploinsufficiency of GRN is also associated with frontotemporal lobar degeneration34.”
From Rare variant associations with plasma protein levels in the UK Biobank (2023) · cites this paper as [34]
In the citing paper
“We also identified two lysosomal proteins, GRN and TMEM106B80,81, that are associated with frontotemporal dementia (FTD)82,83 but were also identified in the latest AD risk GWAS23.”
From Proteogenomic analysis of human cerebrospinal fluid identifies neurologically relevant regulation and implicates causal proteins for Alzheimer’s disease (2024) · cites this paper as [83]
In the citing paper
“The most common genes linked to familial FTD are MAPT, progranulin (GRN), and chromosome 9 open reading frame 72 (C9orf72).”
From New developments of biofluid‐based biomarkers for routine diagnosis and disease trajectories in frontotemporal dementia (2022) · cites this paper as [37]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498 · cited 1×
“These include the mitogen-activated protein kinase (MAPK) and phosphatidylinositol-3-OH kinase (PI(3)K) cascades(14,28), both of which regulate crucial functions in neurons.”
BackgroundSelf-citationCruts, M., Gijselinck, I., van der Zee, J., Engelborghs, S., Wils, H., Pirici, D., Rademakers, R., Vandenberghe, R., Dermaut, B., Martin, J.-J., et al. (2006) · Nature · doi:10.1038/nature05017 · Cited by 1,512
Self-citationClinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups.
(1994) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.57.4.416 · Cited by 1,331
Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics
Maquat, L. E. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1310 · Cited by 1,214
ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis
Greenway, M. J., Andersen, P. M., Russ, C., Ennis, S., Cashman, S., Donaghy, C., Patterson, V., Swingler, R., Kieran, D., Prehn, J., et al. (2006) · Nature Genetics · doi:10.1038/ng1742 · Cited by 667
Frontotemporal dementia and parkinsonism linked to chromosome 17: A consensus conference
Foster, N. L., Wilhelmsen, K., Sima, A. A. F., Jones, M. Z., D'Amato, C. J., Gilman, S., & Participants, C. (1997) · Annals of Neurology · doi:10.1002/ana.410410606 · Cited by 634
Progranulin is a mediator of the wound response
He, Z., Ong, C. H. P., Halper, J., & Bateman, A. (2003) · Nature Medicine · doi:10.1038/nm816 · Cited by 490
He, Z., & Bateman, A. (2003) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0474-3 · Cited by 476
Cellular Localization of Gene Expression for Progranulin
Daniel, R., He, Z., Carmichael, K. P., Halper, J., & Bateman, A. (2000) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540004800713 · Cited by 346
Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice
Capsoni, S., Ugolini, G., Comparini, A., Ruberti, F., Berardi, N., & Cattaneo, A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.12.6826 · Cited by 277
Research works printed but not linked: 1
- Froelich, S. et al. Mapping of a disease locus for familial rapidly progressive frontotemporal dementia to chromosome 17q12–21. Am. J. Med. Genet. 74, 380–385 (1997) · doi:10.1002/(sici)1096-8628(19970725)74:4<380::aid-ajmg8>3.0.co;2-t
Cited by
Items 801–900 of 1,018
Moreaud, O., Belliard, S., Snowden, J. S., Auriacombe, S., Basaglia-Pappas, S., Bernard, F., Bon, L., Boutantin, J., Boutoleau‐Bretonnière, C., Charnallet, A., et al. (2008) · Revue Neurologique · doi:10.1016/j.neurol.2008.02.031 · Cited by 43
Self-citationFrontotemporal Lobar Degeneration
Josephs, K. A. (2007) · Neurologic Clinics · doi:10.1016/j.ncl.2007.03.005 · Cited by 51
Inflammation in Neurodegenerative Disorders: Friend or Foe?
Galimberti, D., Fenoglio, C., & Scarpini, E. (2008) · Current Aging Sciencee · doi:10.2174/1874609810801010030 · Cited by 41
A Shift to Organismal Stress Resistance in Programmed Cell Death Mutants
Judy, M. E., Nakamura, A., Huang, A., Grant, H. E., McCurdy, H., Weiberth, K. F., Gao, F., Coppola, G., Kenyon, C. J., & Kao, A. W. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003714 · Cited by 42
Frontotemporal lobar degeneration: current knowledge and future challenges
Cerami, C., Scarpini, E. A., Cappa, S. F., & Galimberti, D. (2012) · Journal of Neurology · doi:10.1007/s00415-012-6507-5 · Cited by 42
Göbel, M., Eisele, L., Möllmann, M., Hüttmann, A., Johansson, P., Scholtysik, R., Bergmann, M., Busch, R. M., Döhner, H., Hallek, M. J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072107 · Cited by 40
Reduction of polyglutamine toxicity by TDP-43, FUS and progranulin in Huntington's disease models
Tauffenberger, A., Chitramuthu, B. P., Bateman, A., Bennett, H. P., & Parker, J. A. (2013) · Human Molecular Genetics · doi:10.1093/hmg/dds485 · Cited by 40
Analyses MAPT, GRN, and C9orf72 mutations in Chinese patients with frontotemporal dementia
Tang, M., Gu, X., Wei, J., Jiao, B., Zhou, L., Zhou, Y., Weng, L., Yan, X., Tang, B., Xu, J. L., et al. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.05.013 · Cited by 42
Hosokawa, M., Kondo, H., Serrano, G. E., Beach, T. G., Robinson, A., Mann, D. M. A., Akiyama, H., Hasegawa, M., & Arai, T. (2017) · Scientific Reports · doi:10.1038/s41598-017-01587-6 · Cited by 40
Self-citationProgranulin: Functions and neurologic correlations
Townley, R. A., Boeve, B. F., & Benarroch, E. E. (2018) · Neurology · doi:10.1212/wnl.0000000000004840 · Cited by 40
Self-citationDevelopmental synapse remodeling in the cerebellum and visual thalamus
Kano, M., & Watanabe, T. (2019) · F1000Research · doi:10.12688/f1000research.18903.1 · Cited by 40
On the ‘classification’ of neurodegenerative disorders: discrete entities, overlap or continuum?
Armstrong, R. A. (2012) · Folia Neuropathologica · doi:10.5114/fn.2012.30521 · Cited by 48
Update on Recent Molecular and Genetic Advances in Frontotemporal Lobar Degeneration
Bigio, E. H. (2008) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/nen.0b013e31817d751c · Cited by 40
An update on the toxicity of Aβ in Alzheimer’s disease
Götz, J., Ittner, L. M., Schönrock, N., & Cappai, R. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s3016 · Cited by 50
Riku, Y., Watanabe, H., Yoshida, M., Tatsumi, S., Mimuro, M., Iwasaki, Y., Katsuno, M., Iguchi, Y., Masuda, M., Senda, J., et al. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.5489 · Cited by 40
Progranulin: An emerging target for FTLD therapies
Gass, J., Prudencio, M., Stetler, C., & Petrucelli, L. (2012) · Brain Research · doi:10.1016/j.brainres.2012.01.047 · Cited by 39
Self-citationWDR41 supports lysosomal response to changes in amino acid availability
Amick, J., Tharkeshwar, A. K., Amaya, & Ferguson, S. M. (2018) · Molecular Biology of the Cell · doi:10.1091/mbc.e17-12-0703 · Cited by 39
“…have implicated multiple genes related to endolysosome function such as GRN, SQSTM1, CHMP2B, OPTN, and TBK1 as risk factors for these diseases (Skibinski et al., 2005; Baker et al., 2006; Cruts et al., 2006; Maruyama et al., 2010; Fecto et al., 2011; Rubino et al., 2012; Freischmidt et al., 2015).”
BackgroundRoot, J., Mendsaikhan, A., Taylor, G., Merino, P., Nandy, S., Wang, M., Araujo, L. T., Ryu, D., Holler, C., Thompson, B. M., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114985 · Cited by 39
Goldman, J. S. (2012) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-012-0296-1 · Cited by 45
Corrado, L., Battistini, S., Penco, S., Bergamaschi, L., Testa, L., Ricci, C., Giannini, F., Greco, G., Patrosso, M. C., Pileggi, S., et al. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.03.009 · Cited by 44
Kim, E., Kim, Y.-E., Jang, J., Cho, E., Na, D. L., Seo, S. W., Jung, N., Jeong, J. H., Kwon, J. C., Park, K. H., et al. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.06.031 · Cited by 43
Geier, E. G., Bourdenx, M., Storm, N. J., Cochran, J. N., Sirkis, D. W., Hwang, J.-H., Bonham, L. W., Ramos, E. M., Diaz, A., Van Berlo, V., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-018-1925-9 · Cited by 39
Butler, V. J., Gao, F., Corrales, C. I., Cortopassi, W. A., Caballero, B., Vohra, M., Ashrafi, K., Cuervo, A. M., Jacobson, M. P., Coppola, G., et al. (2019) · PLOS Genetics · doi:10.1371/journal.pgen.1008295 · Cited by 39
Progranulin in neurodegenerative dementia
Wang, X., Zeng, P. H., Fang, Y., Zhang, T., & Tian, Q. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15378 · Cited by 40
Behavioral and language variants of frontotemporal dementia: A review of key symptoms
Laforce, R. J. (2013) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2013.09.031 · Cited by 48
Sieh, W., Choi, Y., Chapman, N. H., Craig, U.-K., Steinbart, E. J., Rothstein, J. H., Oyanagi, K., Garruto, R. M., Bird, T. D., Galasko, D. R., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp300 · Cited by 39
No association of TDP-43 with sporadic frontotemporal dementia
Schumacher, A., Friedrich, P., Diehl‐Schmid, J., Ibach, B., Perneczky, R., Eisele, T., Vukovich, R., Förstl, H., & Riemenschneider, M. J. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.05.022 · Cited by 39
Ubiquitin associated protein 1 is a risk factor for frontotemporal lobar degeneration
Rollinson, S., Rizzu, P., Sikkink, S., Baker, M., Halliwell, N., Snowden, J., Traynor, B. J., Ruano, D., Cairns, N., Rohrer, J. D., et al. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.01.009 · Cited by 39
Self-citationFrings, L., Mader, I., Landwehrmeyer, B. G., Weiller, C., Hüll, M., & Huppertz, H. (2012) · Human Brain Mapping · doi:10.1002/hbm.21304 · Cited by 38
Chen, Y., Wang, C., Xie, K., Lei, M., Chai, Y.-S., Xu, F., & Lin, S. (2020) · Mediators of Inflammation · doi:10.1155/2020/9704327 · Cited by 42
Heterosexual Pedophilia in a Frontotemporal Dementia Patient with a Mutation in the Progranulin Gene
Rainero, I., Rubino, E., Negro, E., Gallone, S., Galimberti, D., Gentile, S., Scarpini, E. A., & Pinessi, L. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.06.015 · Cited by 38
Genetics of Frontotemporal Lobar Degeneration
Galimberti, D., & Scarpini, E. A. (2012) · Frontiers in Neurology · doi:10.3389/fneur.2012.00052 · Cited by 44
Alzheimer's disease risk alleles in TREM2 illuminate innate immunity in Alzheimer's disease
Golde, T. E., Streit, W. J., & Chakrabarty, P. (2013) · Alzheimer's Research & Therapy · doi:10.1186/alzrt178 · Cited by 38
Does hyperglycemia downregulate glucose transporters in the brain?
Leão, L. L., Tangen, G. G., Barca, M. L., Engedal, K., Santos, S. H. S., Machado, F. S. M., de Paula, A. M. B., & Monteiro-Júnior, R. S. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.109614 · Cited by 47
New insights and therapeutic opportunities for progranulin-deficient frontotemporal dementia
Amin, S., Carling, G., & Gan, L. (2021) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2021.10.001 · Cited by 38
Wei, F., Jiang, Z., Sun, H., Pu, J., Sun, Y., Wang, M., Tong, Q., Bi, Y., Ma, X., Gao, G. F., et al. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1008062 · Cited by 41
Saeedi‐Boroujeni, A., Purrahman, D., Shojaeian, A., Poniatowski, Ł. A., Rafiee, F., & Mahmoudian‐Sani, M. (2023) · Journal of Inflammation · doi:10.1186/s12950-023-00327-0 · Cited by 42
Low plasma progranulin levels in children with autism
AL-Ayadhi, L. Y., & Mostafa, G. A. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-111 · Cited by 37
Petkau, T. L., Hill, A., & Leavitt, B. R. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.12.006 · Cited by 36
Disease-modifying effects of metabolic perturbations in ALS/FTLD
Jawaid, A., Khan, R., Polymenidou, M., & Schulz, P. E. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0294-0 · Cited by 37
Progranulin Regulates Inflammation and Tumor
Liu, C., Li, J., Shi, W., Zhang, L., Liu, S., Lian, Y., Liang, S., & Wang, H. (2019) · Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry · doi:10.2174/1871523018666190724124214 · Cited by 38
Emerging Role of Genetic Alterations Affecting Exosome Biology in Neurodegenerative Diseases
Riva, P., Battaglia, C., & Venturin, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174113 · Cited by 37
The novel Tau mutation G335S: clinical, neuropathological and molecular characterization
Spina, S., Murrell, J. R., Yoshida, H., Ghetti, B. F., Bermingham, N., Sweeney, B. J., Dlouhy, S. R., Crowther, R. A., Goedert, M., & Keohane, C. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0182-5 · Cited by 41
Sha, S. J., Miller, Z. A., Min, S., Zhou, Y., Brown, J., Mitic, L. L., Karydas, A., Koestler, M., Tsai, R., Corbetta‐Rastelli, C., et al. (2017) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2017.08.002 · Cited by 36
Progranulin as a candidate biomarker for therapeutic trial in patients with ALS and FTLD
Feneberg, E., Steinacker, P., Volk, A. E., Weishaupt, J. H., Wollmer, M. A., Boxer, A., Tumani, H., Ludolph, A. C., & Otto, M. (2016) · Journal of Neural Transmission · doi:10.1007/s00702-015-1486-1 · Cited by 36
In vivo evidence for pre‐symptomatic neuroinflammation in a MAPT mutation carrier
Bevan‐Jones, W. R., Cope, T. E., Jones, P. S., Passamonti, L., Hong, Y. T., Fryer, T., Arnold, R., Coles, J. P., Aigbirhio, F. I., O'Brien, J. T., et al. (2019) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.683 · Cited by 36
The complex aetiology of frontotemporal lobar degeneration
Pickering-Brown, S. M. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.03.017 · Cited by 48
Self-citationTanimoto, R., Palladino, C., Xu, S., Buraschi, S., Neill, T., Gomella, L. G., Peiper, S. C., Belfiore, A., Iozzo, R. V., & Morrione, A. (2017) · Matrix Biology · doi:10.1016/j.matbio.2017.04.001 · Cited by 43
Partial Tmem106b reduction does not correct abnormalities due to progranulin haploinsufficiency
Arrant, A. E., Nicholson, A. M., Zhou, X., Rademakers, R., & Roberson, E. D. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0264-6 · Cited by 35
Self-citationHyung, S., Im, S., Lee, B. Y., Shin, J., Park, J., Lee, C., Suh, J. F., & Hur, E. (2018) · Glia · doi:10.1002/glia.23547 · Cited by 38
Frew, J., Baradaran‐Heravi, A., Balgi, A. D., Wu, X., Yan, T. D., Arns, S., Shidmoossavee, F. S., Tan, J. S. C., Jaquith, J. B., Jansen‐West, K. R., et al. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00369-5 · Cited by 37
Self-citationPaisán‐Ruiz, C., Nath, P., Wood, N. W., Singleton, A., & Houlden, H. (2008) · European Journal of Neurology · doi:10.1111/j.1468-1331.2008.02247.x · Cited by 36
“Frontotemporoparietal” dementia: Clinical phenotype associated with the c.709-1G>A PGRN mutation
Moreno, F., Indakoetxea, B., Barandiaran, M., Alzualde, A., Gabilondo, A., Estanga, A., Ruiz, J., Ruibal, M., Bergareche, A., Martí-Massó, J. F., et al. (2009) · Neurology · doi:10.1212/wnl.0b013e3181bd82a7 · Cited by 36
AZP2006, a new promising treatment for Alzheimer’s and related diseases
Callizot, N., Estrella, C., Burlet, S., Henriques, A., Brantis, C., Barrier, M., Campanari, M. L., & Verwaerde, P. (2021) · Scientific Reports · doi:10.1038/s41598-021-94708-1 · Cited by 35
TDP-43 Proteinopathy and Tauopathy: Do They Have Pathomechanistic Links?
Riku, Y., Yoshida, M., Iwasaki, Y., Sobue, G., Katsuno, M., & Ishigaki, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415755 · Cited by 38
Sampognaro, P. J., Arya, S., Knudsen, G. M., Gunderson, E. L., Sandoval-Perez, A., Hodul, M., Bowles, K., Craik, C. S., Jacobson, M. P., & Kao, A. W. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00621-8 · Cited by 35
Flanagan, E. P., Baker, M., Perkerson, R. B., Duffy, J. R., Strand, E. A., Whitwell, J. L., Machulda, M. M., Rademakers, R., & Josephs, K. A. (2015) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000375299 · Cited by 39
Self-citationLu, Y., Lin, Z., Zhang, W., Feng, T., Liu, J., Wang, X., Yu, Y., Qi, M., Zhao, W., Yu, X., et al. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.05.025 · Cited by 36
Learning and memory with neuropathic pain: impact of old age and progranulin deficiency
Albuquerque, B., Häußler, A., Vannoni, E., Wolfer, D. P., & Tegeder, I. (2013) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2013.00174 · Cited by 35
Sortilin and SorLA Regulate Neuronal Sorting of Trophic and Dementia-Linked Proteins
Pallesen, L. T., & Vægter, C. B. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8236-2 · Cited by 36
Frontotemporal Dementia and Pharmacologic Interventions
Kaye, E. D., Petrovic‐Poljak, A., Verhoeff, N. P. L. G., & Freedman, M. (2010) · Journal of Neuropsychiatry · doi:10.1176/jnp.2010.22.1.19 · Cited by 42
Escamilla, M., Hare, E., Dassori, A. M., Peralta, J. M., Ontiveros, A., Nicolini, H., Raventós, H., Medina, R., Mendoza, R., Jerez, A., et al. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08040612 · Cited by 38
Li, S., Chen, Y., Sun, D., Bai, R., Gao, X., Yang, Y., Sheng, J., & Xu, Z. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0396-7 · Cited by 36
Petkau, T. L., Kosior, N., de Asis, K., Connolly, C., & Leavitt, B. R. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-1000-9 · Cited by 35
Changing perspectives on frontotemporal dementia: A review
Snowden, J. S. (2022) · Journal of Neuropsychology · doi:10.1111/jnp.12297 · Cited by 51
Self-citationThe behavioral variant of frontotemporal dementia: linking neuropathology to social cognition
Cerami, C., & Cappa, S. F. (2013) · Neurological Sciences · doi:10.1007/s10072-013-1317-9 · Cited by 38
Desmarais, J. A., Cao, M., Bateman, A., & Murphy, B. D. (2008) · Reproduction · doi:10.1530/rep-08-0044 · Cited by 35
Alquézar, C., de la Encarnación, A., Moreno, F., de Munaín, A. L., & Martín‐Requero, Á. (2016) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.150131 · Cited by 39
Gossye, H., Van Broeckhoven, C., & Engelborghs, S. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00757 · Cited by 34
Distinct tau filament folds in human MAPT mutants P301L and P301T
Schweighauser, M., Shi, Y., Murzin, A. G., Garringer, H. J., Vidal, R., Murrell, J. R., Erro, M. E., Seelaar, H., Ferrer, I., Swieten, J. C. V., et al. (2025) · Nature Structural & Molecular Biology · doi:10.1038/s41594-025-01575-9 · Cited by 37
Update on Hippocampal Sclerosis
Dutra, J. R., Cortes, E. P., & Vonsattel, J. P. (2015) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-015-0592-7 · Cited by 34
Progressive amnestic dementia, hippocampal sclerosis, and mutation in C9ORF72
Murray, M. E., Bieniek, K. F., Banks Greenberg, M., DeJesus-Hernandez, M., Rutherford, N. J., van Blitterswijk, M., Niemantsverdriet, E., Ash, P. E., Gendron, T. F., Kouri, N., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1161-2 · Cited by 35
Self-citationRecent advances in the molecular genetics of frontotemporal lobar degeneration
Rainero, I., Rubino, E., Michelerio, A., D'Agata, F., Gentile, S., & Pinessi, L. (2017) · Functional Neurology · doi:10.11138/fneur/2017.32.1.007 · Cited by 40
Analysis of neurodegenerative Mendelian genes in clinically diagnosed Alzheimer Disease
Fernández, M. V., Kim, J. H., Budde, J., Black, K., Medvedeva, A., Saef, B. A., Deming, Y. K., Del‐Aguila, J. L., Ibáñez, L., Dube, U., et al. (2017) · PLoS Genetics · doi:10.1371/journal.pgen.1007045 · Cited by 37
Fostinelli, S., Ciani, M., Zanardini, R., Zanetti, O. O., Binetti, G. G., Ghidoni, R., & Benussi, L. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170661 · Cited by 36
A History of Senile Plaques: From Alzheimer to Amyloid Imaging
Beach, T. G. (2022) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlac030 · Cited by 41
Capell, A., Fellerer, K., & Haass, C. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.560128 · Cited by 36
The molecular basis for development of proinflammatory autoantibodies to progranulin
Thurner, L., Fadle, N., Regitz, E., Kemele, M., Klemm, P., Zaks, M., Stöger, E., Bette, B., Carbon, G., Zimmer, V., et al. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.05.002 · Cited by 34
Frontotemporal dementia: Past, present, and future
Ulugut, H., & Pijnenburg, Y. A. L. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.13363 · Cited by 33
A review on primary progressive aphasia
Johnson, N. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s1493 · Cited by 38
Porta, S., Kwong, L. K., Trojanowski, J. Q., & Lee, V. M. ‐. (2015) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000182 · Cited by 36
Capozzo, R., Sassi, C., Hammer, M. B., Arcuti, S., Zecca, C., Barulli, M. R., Tortelli, R., Gibbs, J. R., Crews, C., Seripa, D., et al. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.01.011 · Cited by 33
Takeda, T. (2017) · Neuropathology · doi:10.1111/neup.12428 · Cited by 36
Loss of Neuroprotective Factors in Neurodegenerative Dementias: The End or the Starting Point?
Benussi, L., Binetti, G., & Ghidoni, R. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00672 · Cited by 33
The role of lysosomes and autophagosomes in frontotemporal lobar degeneration
Bain, H. D. C., Davidson, Y. S., Robinson, A. C., Ryan, S., Rollinson, S., Richardson, A., Jones, M., Snowden, J. S., Pickering‐Brown, S., & Mann, D. M. A. (2019) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12500 · Cited by 33
Self-citationOlm, C. A., McMillan, C. T., Irwin, D. J., Deerlin, V. M. V., Cook, P. A., Gee, J. C., & Grossman, M. (2018) · NeuroImage Clinical · doi:10.1016/j.nicl.2018.05.017 · Cited by 41
Parkinsonism in frontotemporal dementias
Rowe, J. B. (2019) · International review of neurobiology · doi:10.1016/bs.irn.2019.10.012 · Cited by 41
Anoar, S., Woodling, N. S., & Niccoli, T. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.786076 · Cited by 39
Devenney, E. M., Ahmed, R. M., & Hodges, J. R. (2019) · Handbook of clinical neurology · doi:10.1016/b978-0-12-804766-8.00015-7 · Cited by 46
Differential regulation of progranulin derived granulin peptides
Zhang, T., Du, H., Santos, M. N., Wu, X., Pagan, M. D., Trigiani, L. J., Nishimura, N., Reinheckel, T., & Hu, F. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00513-9 · Cited by 36
Low prevalence of progranulin mutations in Finnish patients with frontotemporal lobar degeneration
Krüger, J., Kaivorinne, A.-L., Udd, B., Majamaa, K., & Remes, A. M. (2008) · European Journal of Neurology · doi:10.1111/j.1468-1331.2008.02272.x · Cited by 47
Hypoxia induces up-regulation of progranulin in neuroblastoma cell lines
Piscopo, P., Rivabene, R., Adduci, A., Mallozzi, C., Malvezzi‐Campeggi, L., Crestini, A., & Confaloni, A. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.09.008 · Cited by 33
Cognitive Reserve in Granulin-Related Frontotemporal Dementia: from Preclinical to Clinical Stages
Premi, E., Gazzina, S., Bozzali, M., Archetti, S., Alberici, A., Cercignani, M., Bianchetti, A., Gasparotti, R., Turla, M., Caltagirone, C., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074762 · Cited by 38
Novel progranulin mutation: Screening for PGRN mutations in a Portuguese series of FTD/CBS cases
Guerreiro, R. J., Santana, I. J., Brás, J., Révész, T., Rebelo, O., Ribeiro, M. H., Santiago, B., Oliveira, C. R., Singleton, A., & Hardy, J. (2008) · Movement Disorders · doi:10.1002/mds.22078 · Cited by 38
Tomiyama, H., Kokubo, Y., Sasaki, R., Li, Y., Imamichi, Y., Funayama, M., Mizuno, Y., Hattori, N., & Kuzuhara, S. (2008) · Movement Disorders · doi:10.1002/mds.22262 · Cited by 37
Clinical Features of Pathologic Subtypes of Behavioral-Variant Frontotemporal Dementia
Hu, W. T., Mandrekar, J. N., Parisi, J. E., Knopman, D. S., Boeve, B. F., Petersen, R. C., Hutton, M., Dickson, D. W., & Josephs, K. A. (2007) · Archives of Neurology · doi:10.1001/archneur.64.11.1611 · Cited by 33
Self-citationHerman, M., Randall, G. W., Spiegel, J. L., Maldonado, D. J., & Simoes, S. (2024) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2022.0387 · Cited by 34
Colombrita, C., Onesto, E., Tiloca, C., Ticozzi, N., Silani, V., & Ratti, A. (2011) · PubMed · doi:10.4449/aib.v149i1.1261 · Cited by 41
Tian, Q., Zhao, S., & Liu, C.-J. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-0669-7_14 · Cited by 32
Gaowa, S., Bao, N., Da, M., Qiburi, Q., Ganbold, T., Chen, L., Altangerel, A., Temuqile, T., & Baigude, H. (2018) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2018.05.011 · Cited by 34
Metadata
- Authors
- Baker, M., Mackenzie, I. R., Pickering-Brown, S. M., Gass, J., Rademakers, R., Lindholm, C., Snowden, J., Adamson, J., Sadovnick, A. D., Rollinson, S., Cannon, A., Dwosh, E., Neary, D., Melquist, S., Richardson, A., Dickson, D., Berger, Z., Eriksen, J., Robinson, T., Zehr, C., Dickey, C. A., Crook, R., McGowan, E., Mann, D., Boeve, B., Feldman, H., & Hutton, M.
- Affiliations
- Mayo Clinic in Florida (US)
- University of Manchester (GB)
- University of British Columbia (CA)
- Mayo Clinic (US)
- Corresponding author
- Mackenzie, Ian R.
- Hutton, Mike
- ORCID
- Baker, Matt
- Mackenzie, Ian R.
- Pickering-Brown, Stuart M.
- Gass, Jennifer
- Rademakers, Rosa
- Snowden, Julie
- Sadovnick, A. Dessa
- Rollinson, Sara
- Cannon, Ashley
- Dwosh, Emily
- Neary, David
- Melquist, Stacey
- Richardson, Anna
- Dickson, Dennis
- Berger, Zdenek
- Eriksen, Jason
- Dickey, Chad A.
- Crook, Richard
- McGowan, Eileen
- Mann, David
- Boeve, Bradley
- Feldman, Howard
- Venue
- Nature
- Published
- 2006-07-16
- Volume
- 442
- Issue
- 7105
- Pages
- 916-919
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2027460468
- Cited by
- 2,058
- References
- 31
- Citations by year
- 2026: 56 · 2025: 77 · 2024: 102 · 2023: 94 · 2022: 93 · 2021: 115 · 2020: 89 · 2019: 114 · 2018: 88 · 2017: 109 · 2016: 103 · 2015: 81 · 2014: 89 · 2013: 107 · 2012: 110
- FWCI
- 86.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- progranulin, frontotemporal dementia, chromosome 17q21, MAPT, ubiquitin-positive inclusions, neuronal intranuclear inclusions, neurodegeneration, familial dementia, null alleles, growth factors, FTDP-17
- MeSH terms
- Progranulins, Cell Survival, Chromosomes, Human, Pair 17, Dementia, Frontal Lobe, Humans, Genetic Linkage, Mutation, Neurons, Protein Precursors, RNA, Messenger, Temporal Lobe, tau Proteins, Codon, Terminator, Physical Chromosome Mapping, RNA Stability, Intercellular Signaling Peptides and Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.